Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAALV29042
Magnesium Glycinate Bisglycinate + Vitamine B6 Haute dose 1422 mg, 180 Gélules- Origine Angleterre UK
hero
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
26
▼ 10.3% vs prev 4w
Year-over-year
-42.2%
vs same 4w last year (45 units)
Current stock
4
≈ 0.5 weeks of cover
Unit price
MAD 295
avg of last 30 sells · latest 2026-05-07
AAALV29042
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-06-08 · Total forecast: 261 units.
Actual
Forecast p50 (expected)
Forecast p95 (upper bound)
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate + Vitamine B6 Haute dose 1422 mg, 180 Gélules- Origine Angleterre UK · in the hero cohort · last 4 weeks 26 units, trending down -10.3% · on-hand 4 units
Signals the model saw
- Cohort: hero (567 days of history, 535 units sold over 52 weeks)
- Volatility (CV): 0.70 — moderate
- Recent trend: last 4w = 26 units · prev 4w = 29 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic (p50) — next week | 4.7 units |
| Realistic (p50) — next 4 weeks | 24.7 units |
| Realistic (p50) — next 3 months | 77.3 units |
| Optimistic (p95) — next week | 14.4 units |
| Optimistic (p95) — next 4 weeks (reorder target) | 78.0 units |
| Optimistic (p95) — next 3 months (quarterly PO target) | 260.6 units |
| Legacy μ/wk (reorder pipeline) | 6.0 |
| Revenue exposure — optimistic, 3 months | MAD 76.8K |